Yong Zang
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 15, 2025
A model-free phase I/II dose optimization design for immunotherapy trials.Yingjie Qiu, Mengyi Lu, Yan Han
|Dec 08, 2023
A Bayesian adaptive biomarker stratified phase II randomized clinical trial design for radiotherapies with competing risk survival outcomes.Jina Park, Wenjing Hu, Ick Hoon Jin
|Mar 15, 2023
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect.Mu Shan, Beibei Guo, Hao Liu
|Mar 25, 2022
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trials.Yifei Zhang, Beibei Guo, Sha Cao
|Feb 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy.Beibei Guo, Yong Zang
|Dec 22, 2020
CWL: A conditional weighted likelihood method to account for the delayed joint toxicity-efficacy outcomes for phase I/II clinical trials.Yifei Zhang, Yong Zang
Pageof 1
